It has been found in a recent report that Drug Enforcement Administration (DEA) had put suspension order to the Cardinal Health Inc., which has now been blocked by the company as it filed a case against the DEA.

The report has revealed that DEA had ordered a suspension on Cardinal Health’s license which was issued for distribution of potentially addictive medicines. It has been found that the DEA deemed that Cardinal was aware of the fact that the pharmacies were filling for oxycodone prescribed by physicians for illicit reasons and thus, it announced the suspension of the company’s license.

As per the U. S. District court hearing, Cardinal Health claimed that it would win the case against the Order to Show Cause and Immediate Suspension of Registration issued to Florida distribution facility for distributing potentially addictive medicines. The company told the court that DEA has alleged it, just because additional shipments were made by the company to four pharmacies.

Also, it is not evident from the extra shipments that products were transported to pharmacies for recreational use, says the company. In addition, it is also being clarified by the dispute that DEA had issues from firms that create painkillers, stimulants and tranquilizers. And it suspended Cardinal’s license to supply the products from Florida because the city was biggest victim of the problem of drug abuse.

It has further also been revealed that the plaintiff is not supplying the controlled substances to the four pharmacies that were identified and therefore, it was not important to address DEA’s allegation. In addition, the Cardinal Health Inc. has itself taken a pledge not to sell controlled substances to any pharmacy as it is an illegal activity according to the DEA.